If you liked this article you might like

Cramer's 'Mad Money' Recap: Now, the Focus Is Earnings

Investors Shun Bed Bath & Beyond, Walgreens Growth Deals

Bed Bath & Beyond Deal Shows Right Kind of Risk Taking